Literature DB >> 10615306

What to do with the patient with recurrent vulvovaginal candidiasis.

J S Bingham1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10615306      PMCID: PMC1758221          DOI: 10.1136/sti.75.4.225

Source DB:  PubMed          Journal:  Sex Transm Infect        ISSN: 1368-4973            Impact factor:   3.519


× No keyword cloud information.
  16 in total

1.  Lactobacillus prophylaxis for Candida vaginitis.

Authors:  D J Drutz
Journal:  Ann Intern Med       Date:  1992-03-01       Impact factor: 25.391

Review 2.  Recurrent vulvovaginal candidosis.

Authors:  D J White; M Emens; M Shahmanesh
Journal:  Int J STD AIDS       Date:  1991 Jul-Aug       Impact factor: 1.359

3.  Successful use of boric acid to control azole-refractory Candida vaginitis in a woman with AIDS.

Authors:  Y T Shinohara; S A Tasker
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1997-11-01

4.  Treatment of Torulopsis glabrata vaginitis: retrospective review of boric acid therapy.

Authors:  J D Sobel; W Chaim
Journal:  Clin Infect Dis       Date:  1997-04       Impact factor: 9.079

5.  Torulopsis glabrata vaginitis: clinical aspects and susceptibility to antifungal agents.

Authors:  V Redondo-Lopez; M Lynch; C Schmitt; R Cook; J D Sobel
Journal:  Obstet Gynecol       Date:  1990-10       Impact factor: 7.661

Review 6.  Pathogenesis and treatment of recurrent vulvovaginal candidiasis.

Authors:  J D Sobel
Journal:  Clin Infect Dis       Date:  1992-03       Impact factor: 9.079

7.  Recurrent allergic vulvovaginitis: treatment with Candida albicans allergen immunotherapy.

Authors:  D Rigg; M M Miller; W J Metzger
Journal:  Am J Obstet Gynecol       Date:  1990-02       Impact factor: 8.661

8.  Antifungal agents vs. boric acid for treating chronic mycotic vulvovaginitis.

Authors:  R Jovanovic; E Congema; H T Nguyen
Journal:  J Reprod Med       Date:  1991-08       Impact factor: 0.142

9.  Ingestion of yogurt containing Lactobacillus acidophilus as prophylaxis for candidal vaginitis.

Authors:  E Hilton; H D Isenberg; P Alperstein; K France; M T Borenstein
Journal:  Ann Intern Med       Date:  1992-03-01       Impact factor: 25.391

10.  Depo-Provera in the treatment of recurrent vulvovaginal candidiasis.

Authors:  G J Dennerstein
Journal:  J Reprod Med       Date:  1986-09       Impact factor: 0.142

View more
  1 in total

1.  Combined topical flucytosine and amphotericin B for refractory vaginal Candida glabrata infections.

Authors:  D J White; A R Habib; A Vanthuyne; S Langford; M Symonds
Journal:  Sex Transm Infect       Date:  2001-06       Impact factor: 3.519

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.